Evidence map›Paper›PMID 31194857›Full record

ArticlePLoS pathogens2019

Functional paralysis of human natural killer cells by alphaherpesviruses.

Tessa Mollie Campbell, Brian Patrick McSharry, Megan Steain, Tiffany Ann Russell, David Carl Tscharke, Jarrod John Kennedy, Barry Slobedman, Allison Abendroth

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 26 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Biological relevance ofMicrobiology and molecular biology reviews : MMBR · 2025
    Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Tessa Mollie CampbellDiscipline of Infectious Diseases and Immunology, The University of Sydney, Sydney, New South Wales, Australia.ORCID 0000-0002-7737-2123
Brian Patrick McSharryDiscipline of Infectious Diseases and Immunology, The University of Sydney, Sydney, New South Wales, Australia.ORCID 0000-0003-0473-2789
Megan SteainDiscipline of Infectious Diseases and Immunology, The University of Sydney, Sydney, New South Wales, Australia.ORCID 0000-0002-7631-4204
Tiffany Ann RussellDepartment of Microbial Sciences, University of Surrey, Guildford, Surrey, United Kingdom.ORCID 0000-0003-0188-9393
David Carl TscharkeJohn Curtin School of Medical Research, The Australian National University, Canberra, Australian Capital Territory, Australia.ORCID 0000-0001-6825-9172
Jarrod John KennedyDiscipline of Infectious Diseases and Immunology, The University of Sydney, Sydney, New South Wales, Australia.ORCID 0000-0002-7868-4890
Barry SlobedmanDiscipline of Infectious Diseases and Immunology, The University of Sydney, Sydney, New South Wales, Australia.ORCID 0000-0002-9431-6094
Allison AbendrothDiscipline of Infectious Diseases and Immunology, The University of Sydney, Sydney, New South Wales, Australia.ORCID 0000-0002-9794-4803
The University of Sydney · AUAustralian National University · AUUniversity of Surrey · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Natural killer (NK) cells are implicated as important anti-viral immune effectors in varicella zoster virus (VZV) infection. VZV can productively infect human NK cells, yet it is unknown how, or if, VZV can directly affect NK cell function. Here we demonstrate that VZV potently impairs the ability of NK cells to respond to target cell stimulation in vitro, leading to a loss of both cytotoxic and cytokine responses. Remarkably, not only were VZV infected NK cells affected, but VZV antigen negative NK cells that were exposed to virus in culture were also inhibited. This powerful impairment of function was dependent on direct contact between NK cells and VZV infected inoculum cells. Profiling of the NK cell surface receptor phenotype by multiparameter flow cytometry revealed that functional receptor expression is predominantly stable. Furthermore, inhibited NK cells were still capable of releasing cytotoxic granules when the stimulation signal bypassed receptor/ligand interactions and early signalling, suggesting that VZV paralyses NK cells from responding. Phosflow examination of key components in the degranulation signalling cascade also demonstrated perturbation following culture with VZV. In addition to inhibiting degranulation, IFN-γ and TNF production were also repressed by VZV co-culture, which was most strongly regulated in VZV infected NK cells. Interestingly, the closely related virus, herpes simplex virus type 1 (HSV-1), was also capable of efficiently infecting NK cells in a cell-associated manner, and demonstrated a similar capacity to render NK cells unresponsive to target cell stimulation-however HSV-1 differentially targeted cytokine production compared to VZV. Our findings progress a growing understanding of pathogen inhibition of NK cell function, and reveal a previously unreported strategy for VZV to manipulate the immune response.

Indexed as

AnimalsChlorocebus aethiopsHerpes SimplexHerpesvirus 1, HumanHerpesvirus 3, HumanHumansInterferon-gammaKiller Cells, NaturalSignal TransductionTumor Necrosis Factor-alphaVaricella Zoster Virus InfectionVero CellsIFNG protein, humanInterferon-gammaTumor Necrosis Factor-alpha

Identifiers

PMID31194857
PMCPMC6564036
OpenAlexW2951054112

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.